BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
5.26
-0.10 (-1.87%)
At close: Aug 15, 2025, 3:59 PM
5.17
-1.71%
After-hours: Aug 15, 2025, 07:22 PM EDT

BioNexus Gene Lab Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.12M -1.6M -942.61K -2.21M -2.66M -2.63M -3.09M -562.69K -442.1K -355.97K -109.75K 262.97K 429.89K 751.57K 1.93M 1.58M 1.48M
Depreciation & Amortization
136.94K 153.14K 139.77K 119.99K 113.14K 108.42K 104.82K 101.37K 103.64K 105.42K 105.88K 106.86K 119.81K 108.22K 144.53K 131.06K 103.52K
Stock-Based Compensation
n/a n/a -88.95K -88.95K -88.95K -88.95K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
372.71K 366.25K -80.07K -23.42K -21.79K -457.01K -376.77K -466K -498.56K -338.3K -791.76K 4.12M 8.9M 13.7M 14.05M 9.22M 4.48M
Other Non-Cash Items
-940.27K -849.43K -644.31K 1.09M 1.85M 1.72M 1.58M 58.69K -79.67K -38.81K 101.11K 78.16K 17.44K 11.62K -748.86K -777.93K -754.65K
Deferred Income Tax
n/a n/a -524.55K -524.55K -524.55K -524.55K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
111.48K 115.4K -310.72K -203.34K 149.9K 117.98K 845.68K 1.05M 883.48K 833.38K 455.34K 143.47K -711.25K -862.25K -1.09M -1.1M -120.96K
Operating Cash Flow
-3.02M -2.23M -2.42M -1.86M -1.21M -1.3M -563.44K 643.06K 465.35K 544.03K 552.57K 591.46K -144.11K 9.16K 233.74K -169.27K 708.7K
Capital Expenditures
-205.04K -226.99K -223.9K -158.72K -171.24K -149.4K -165.49K -35.15K -22.08K -54.17K -38.42K -35.17K -34.55K -3.16K -423.5K -423.09K -422.43K
Cash Acquisitions
n/a n/a 26.85K n/a n/a n/a -26.85K n/a n/a n/a n/a n/a n/a n/a 346.01K 346.01K 346.01K
Purchase of Investments
-333.34K -571.57K -510.79K -572.06K -481.33K -320.73K -409.84K -120.36K -353.18K -511.71K -481.52K -548.87K -391.99K -515.84K -808.36K -746.49K -678.38K
Sales Maturities Of Investments
857.43K 1.07M 494.03K 323.82K 237.49K 26.15K 26.85K n/a n/a n/a -22 -74 -74 -74 30.01K 29.83K 29.83K
Other Investing Acitivies
59.41K -48.21K -45.23K -29.69K -107.67K 88.26K 156.6K 115.84K 116.84K 115.38K 43.08K 120.00 34.73K 28.5K 1.76M 1.79M 1.77M
Investing Cash Flow
378.46K 409.26K -98.65K -276.25K -362.37K -382.58K -418.73K -39.66K -258.42K -450.5K -476.88K -584K -391.88K -490.57K 905.71K 998.85K 1.05M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a -34.04K -34.04K -39K -44.99K -17.75K -26.3K -20.39K -12.69K -8.51K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-68.12K -68.13K -70.36K -70.36K -70.36K -61.41K -96.06K -96.06K -96.06K -96.06K -8.56K -22.04K -22.04K -23.04K -20.79K -7.32K -7.32K
Other Financial Acitivies
123.69K 139.84K 11.34K 208.17K 30.32K 4.32K 89.26K 90.11K 242.54K 244.32K 148.26K 149.92K -1.92K -1.92K -2.22K -1.66K -197
Financial Cash Flow
121.73K 149.52K 14.05K 5.96M 5.78M 5.75M 5.74M -7.73K 112.45K 114.23K 109.27K 104.92K -19.67K -28.22K -22.61K -14.15K -5.23K
Net Cash Flow
-3.74M -3.04M -2.01M 3.66M 3.86M 3.81M 4.68M 418.35K 128.89K -5.05K -238.13K -142.37K -630.34K -663.77K 1.01M 754.22K 1.69M
Free Cash Flow
-3.22M -2.44M -2.63M -2.01M -1.38M -1.45M -728.93K 607.91K 443.27K 489.86K 514.15K 556.29K -178.65K 6K -189.76K -592.37K 286.27K